These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 19005872

  • 1. Glucagon-like peptide-2 increases mesenteric blood flow in humans.
    Bremholm L, Hornum M, Henriksen BM, Larsen S, Holst JJ.
    Scand J Gastroenterol; 2009; 44(3):314-9. PubMed ID: 19005872
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. GLP-2 and mesenteric blood flow.
    Hansen LB.
    Dan Med J; 2013 May; 60(5):B4634. PubMed ID: 23673268
    [Abstract] [Full Text] [Related]

  • 5. The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients.
    Bremholm L, Hornum M, Andersen UB, Hartmann B, Holst JJ, Jeppesen PB.
    Regul Pept; 2011 Jun 07; 168(1-3):32-8. PubMed ID: 21421014
    [Abstract] [Full Text] [Related]

  • 6. Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves.
    Taylor-Edwards CC, Burrin DG, Holst JJ, McLeod KR, Harmon DL.
    J Dairy Sci; 2011 Feb 07; 94(2):888-98. PubMed ID: 21257057
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
    Banasch M, Bulut K, Hagemann D, Schrader H, Holst JJ, Schmidt WE, Meier JJ.
    Regul Pept; 2006 Dec 10; 137(3):173-8. PubMed ID: 16928403
    [Abstract] [Full Text] [Related]

  • 9. Duplex ultrasound of the superior mesenteric artery in chronic pancreatitis.
    Hornum M, Larsen S, Olsen O, Pedersen JF.
    Br J Radiol; 2006 Oct 10; 79(946):804-7. PubMed ID: 16822799
    [Abstract] [Full Text] [Related]

  • 10. Effect of fat digestion on superior mesenteric artery blood flow in humans.
    Symersky T, Huisman EJ, Wasser MN, Masclee AA.
    Clin Physiol Funct Imaging; 2007 Jan 10; 27(1):7-11. PubMed ID: 17204031
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients.
    Naimi RM, Madsen KB, Askov-Hansen C, Brandt CF, Hartmann B, Holst JJ, Mortensen PB, Jeppesen PB.
    Regul Pept; 2013 Jun 10; 184():47-53. PubMed ID: 23501043
    [Abstract] [Full Text] [Related]

  • 13. Increased postprandial response of glucagon-like peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
    Hornum M, Pedersen JF, Larsen S, Olsen O, Holst JJ, Knop FK.
    Pancreatology; 2010 Jun 10; 10(2-3):201-7. PubMed ID: 20460948
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in renal artery resistance after meal-induced splanchnic vasodilatation in cirrhotic patients.
    Perney P, Taourel P, Gallix B, Dauzat M, Joomaye Z, Djafari M, Fabro-Peray P, Beaufort P, Petrissans B, Bruel JM, Blanc F.
    J Clin Ultrasound; 2001 Jun 10; 29(9):506-12. PubMed ID: 11745861
    [Abstract] [Full Text] [Related]

  • 16. The effect of warming of the abdomen and of herbal medicine on superior mesenteric artery blood flow - a pilot study.
    Takayama S, Seki T, Watanabe M, Takashima S, Sugita N, Konno S, Iwasaki K, Yambe T, Yoshizawa M, Nitta S, Maruyama S, Yaegashi N.
    Forsch Komplementmed; 2010 Jun 10; 17(4):195-201. PubMed ID: 20829597
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion.
    Sieber CC, Beglinger C, Bart S, Tschoepl M, Currie G, Larsen F, Drewe J.
    Clin Pharmacol Ther; 2004 Jan 10; 75(1):70-9. PubMed ID: 14749693
    [Abstract] [Full Text] [Related]

  • 19. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    J Clin Endocrinol Metab; 1993 Apr 10; 76(4):912-7. PubMed ID: 8473405
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.